Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.48 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.48 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.48 |
| ▸ | ABCG2 | Q9UNQ0 | 9/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.43 |
| ▸ | NMT2 | O60551 | 1/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cromolyn SCHEMBL29352570 | 1.00 | GPR35 (1.00) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL29353205 | 1.00 | GPR35 (1.00) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL4108171 | 0.99 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL8199 | 0.99 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL318268 | 0.99 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| Cromolyn SCHEMBL8662365 | 0.99 | GPR35 (0.97) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL11253121 | 0.96 | GPR35 (0.93) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL2717434 | 0.94 | GPR35 (0.88) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL11175797 | 0.94 | GPR35 (0.88) | GPR35LMNATDP1MEN1KMT2A | |
| SCHEMBL11832140 | 0.94 | GPR35 (0.88) | GPR35LMNATDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 14927 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724079-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Stealth BioTherapeutics Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20260048096-A1 | METHODS AND COMPOSITIONS FOR PRESERVING THE RETINAL OUTER NUCLEAR LAYER (ONL), PHOTORECEPTORS, AND RETINAL THICKNESS | STEALTH BIOTHERAPEUTICS INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4209246-B1 | METHOD OF MANUFACTURING OF A PARTICLE-ATTACHED MICRONEEDLE | QUADMEDICINE INC (KR) | 2026-02-18 | — | — | EP | claimed |
| US-20260041663-A1 | PREVENTION OF ROSACEA INFLAMMATION | UNIV CALIFORNIA (US) | 2026-02-12 | — | — | US | claimed |
| EP-4687912-A1 | GENOTYPE-SPECIFIC METHODS AND SYSTEMS FOR TREATMENT OF NEURODEGENERATIVE DISEASE | Phenonet, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-12545948-B2 | Identification of novel loci in asthma and methods of use thereof for the diagnosis and treatment of asthma | THE CHILDREN'S HOSPITAL OF PHILADELPHIA (US) | 2026-02-10 | — | — | US | claimed |
| EP-4058037-B1 | FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE | SPINALCYTE LLC (US) | 2026-01-28 | — | — | EP | claimed |
| WO-2025235998-A1 | PLURIPOTENT STEM CELL DERIVED MESENCHYMAL STEM CELLS WITH ENHANCED IMMUNE MODULATORY ACTIVITY | IMMORTA BIO, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| EP-4647084-A1 | METHOD FOR TREATING ASTHMA BY USING TSLP ANTIBODY | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2025-11-12 | — | — | EP | claimed |
| EP-0036138-A2 | Composition of matter for topical application comprising a bio-affecting agent and N,N-diethyl-m-toluamide | MERCK & CO. INC. (US) | 1981-09-23 | — | — | EP | claimed |
| US-4271182-A | TOPICAL APPLICATION OF 1,3-BIS((2-CARBOXY-CHROMON-5-)OXY)-2-HYDROXYPROPANE | FISONS LIMITED (GB) | 1981-06-02 | — | — | US | claimed |
| US-4268519-A | Method of treating otitis media | FISONS LIMITED (GB) | 1981-05-19 | — | — | US | claimed |
| US-4268518-A | Method of treating cystitis | FISONS LIMITED (GB) | 1981-05-19 | — | — | US | claimed |
| US-4238502-A | Method of treating psychiatric conditions | FISONS LIMITED (GB) | 1980-12-09 | — | — | US | claimed |
| US-4211777-A | GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1980-07-08 | — | — | US | claimed |
| US-4152448-A | ANTIINFLAMMATORY | FISONS LIMITED (GB) | 1979-05-01 | — | — | US | claimed |
| US-4151292-A | ANTIINFLAMMATORY SIDE EFFECT INHIBITION USING CHROMENE DERIVATIVES, GASTROINTESTINAL DISORDERS | FISONS LIMITED (GB) | 1979-04-24 | — | — | US | claimed |
| US-4146634-A | 1,3-BIS(2-CARBOXYCHROMON-5-YLOXY)-2-HYDROXYPROPANE AS ORAL ANTIULER AGENT | FISONS LIMITED (GB) | 1979-03-27 | — | — | US | claimed |
| US-4145438-A | METHOD FOR TREATMENT OF ECZEMA OR PSORIASIS | FISONS LIMITED (GB) | 1979-03-20 | — | — | US | claimed |